The global anterior uveitis treatment market size is expected to reach USD 967.5 million by 2030, registering a CAGR of 12.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of the disease is anticipated to aid market growth. This disease is more common when compared to panuveitis, posterior, and intermediate uveitis.
Anterior Uveitis Treatment Market Report Highlights
- Corticosteroids dominated the anterior uveitis treatment market in 2023 owing to its beneficial characteristic of minimizing inflammation in the eye. It is the primary treatment modality.
- Anti-TNF agents are expected to exhibit lucrative growth rate over the forecast period due to growing opportunity in treatment methods with biologic therapy using Anti-TNF drugs.
- Immunosuppressants held a significant market share in 2023 owing to their growing adoption for treatment of chronic anterior uveitis.
- Hospital pharmacies dominated the market in 2023 due to the wide treatment options available there.
- Online pharmacies are expected to witness significant CAGR over the forecast period due to convenience, ease, and availability of discounted products.
- North America held the largest revenue share in 2023 owing to high prevalence as well as healthcare expenditure in this region.
- Asia Pacific is anticipated to exhibit lucrative growth during the forecast period due to the rising number of infectious diseases in developing countries of the region and growing disposable income.
For More Details or Sample Copy please visit link @: Anterior Uveitis Treatment Market Report
According to a 2017 article by Retina Today, this condition accounted for around 30% to 90% of the cases of uveitis. It also stated around 1% to 4% of patients experience 25% loss of visual acuity. There are different effective treatments for this disease and can be easily managed; however, it tends to recur. This disease is prevalent among both young and middle-aged group. It is also common among the geriatric population. Ocular ischemia and herpetic uveitis are the two most common causes of this disease among the geriatric population. Most of the cases occur in healthy people, however, some are associated with infectious diseases, gastrointestinal disorders, rheumatologic diseases, and lung & skin diseases. This disease is less sight-threatening as compared to posterior uveitis, however, in some cases might lead to glaucoma, cataract, and cystoid macular edema.
List Of major companies in the Anterior Uveitis Treatment Market
- Novartis AG
- Santen Pharmaceutical Co., Ltd.
- AbbVie Inc.
- Kiora Pharmaceuticals, Inc.
- Clearside Biomedical
- Aldeyra Therapeutics, Inc.
- Aciont Inc.
- Sirion Therapeutics, Inc.
- UCB S.A.
- Lux Biosciences, Inc.
For Customized reports or Special Pricing please visit @: Anterior Uveitis Treatment Market Analysis Report
We have segmented the global anterior uveitis treatment market based on type, therapy, distribution channel, and region.
Research Methodology
We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll-Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
#AnteriorUveitis #EyeHealth #Ophthalmology #MedicalResearch #EyeCare #VisionHealth #UveitisTreatment #HealthTech #MedicalAdvancements #PatientCare #InflammatoryEyeDisease #Optometry #ClinicalTrials #EyeCareInnovation #OcularHealth
Comments
Post a Comment